Direkt zum Inhalt
Merck

855775P

Avanti

18:0 Lyso PC

Avanti Research - A Croda Brand

Synonym(e):

1-octadecanoyl-sn-glycero-3-phosphocholine; PC(18:0/0:0)

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

Empirische Formel (Hill-System):
C26H54NO7P
CAS-Nummer:
Molekulargewicht:
523.68
MDL-Nummer:
UNSPSC-Code:
51191904
NACRES:
NA.25

Beschreibung

1-stearoyl-2-hydroxy-sn-glycero-3-phosphocholine

Assay

>99% (LPC; may contain up to 10% of the 2-LPC isomer, TLC)

Form

powder

Verpackung

pkg of 1 × 1 g (855775P-1g)
pkg of 1 × 200 mg (855775P-200mg)
pkg of 1 × 25 mg (855775P-25mg)
pkg of 1 × 500 mg (855775P-500mg)

Hersteller/Markenname

Avanti Research - A Croda Brand

Versandbedingung

dry ice

Lagertemp.

−20°C

SMILES String

O[C@](COP([O-])(OCC[N+](C)(C)C)=O)([H])COC(CCCCCCCCCCCCCCCCC)=O

InChI

1S/C26H54NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)32-23-25(28)24-34-35(30,31)33-22-21-27(2,3)4/h25,28H,5-24H2,1-4H3

InChIKey

IHNKQIMGVNPMTC-UHFFFAOYSA-N

Anwendung

18:0 Lyso PC has been used:
  • to functionalize carbon nanotubes (CNTs) for the development of methods to attach DNA to CNTs
  • to increase the level of lysophosphatidic acid (LPA) in mouse
  • to induce TNF receptor associated factor 3 interacting protein 2 (TRAF3IP2) expression in endothelial cells (EC)

Verpackung

20 mL Clear Glass Screw Cap Vial (855775P-1g)
20 mL Clear Glass Screw Cap Vial (855775P-500mg)
5 mL Amber Glass Screw Cap Vial (855775P-200mg)
5 mL Amber Glass Screw Cap Vial (855775P-25mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

auch häufig zusammen mit diesem Produkt gekauft

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable


Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumente section.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Kunden haben sich ebenfalls angesehen

OxLDL induces endothelial dysfunction and death via TRAF3IP2: inhibition by HDL3 and AMPK activators
Valente AJ, et al.
Free radical biology & medicine, 70, 117-128 (2014)
Optimising DNA binding to carbon nanotubes by non-covalent methods
Vanesa Sanz
Carbon, 49(5), 1775-1781 (2011)
Anthony J Valente et al.
Free radical biology & medicine, 70, 117-128 (2014-02-25)
Oxidized low-density lipoprotein (oxLDL) induces endothelial cell death through the activation of NF-κB and AP-1 pathways. TRAF3IP2 is a redox-sensitive cytoplasmic adapter protein and an upstream regulator of IKK/NF-κB and JNK/AP-1. Here we show that oxLDL-induced death in human primary
Dumindika A Siriwardane et al.
International journal of pharmaceutics, 578, 119077-119077 (2020-01-29)
Identification and quantification of excipient related degradation products in the liposomal formulation is important, as they may impact the safety and efficacy of the drug. Phospholipids are one of the major excipients in liposome drugs composing the lipid bilayer, and
Otto K Kari et al.
Nanoscale, 12(3), 1728-1741 (2020-01-03)
Methodological constraints have limited our ability to study protein corona formation, slowing nanomedicine development and their successful translation into the clinic. We determined hard and soft corona structural properties along with the corresponding proteomic compositions on liposomes in a label-free

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.